Advancements in artificial pancreas and closed-loop systems are revolutionizing diabetes care by automating glucose regulation. These systems integrate continuous glucose monitors with insulin pumps, enabling real-time adjustments based on glucose fluctuations. Hybrid closed-loop models have significantly improved glycemic control, reducing the burden of frequent insulin adjustments. Innovations in dual-hormone systems, incorporating glucagon alongside insulin, aim to further enhance stability and minimize hypoglycemia risks. While current technology continues to evolve, challenges such as sensor accuracy, accessibility, and cost remain. With ongoing development, fully automated, next-generation artificial pancreas systems are expected to provide more precise, user-friendly solutions for diabetes management.
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
Belize Bible College, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Bridging the gap: Coaching patients on GLP-1s for sustainable outcomes beyond the prescription
Keith Hersey, Master Your GLP-1, United States